What does Pianite do?

Pianite is a specialist medical practice in Overijse. Private Limited, started on 17 November 2011, 1 establishment.

What is the address of Pianite?

The registered office of Pianite is located at Jean Tombeurstraat 19 box a, 3090 Overijse.

Is Pianite still active?

Yes. According to the CBE (15 November 2026) Pianite is active, legal situation “Normale toestand”, started on 17 November 2011.

Is Pianite registered on Peppol?

Yes, Pianite is registered on the Peppol network with ID 0208:0841106103.

What is the enterprise number of Pianite?

The enterprise number of Pianite is BE0841106103.

When was Pianite founded?

Pianite was founded on 17 November 2011.

Who are the directors of Pianite?

According to the 2025 annual accounts, the directors of Pianite are: Tom Van Severen.

Is Pianite a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 November 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Pianite make in 2025?

Pianite posted a profit after taxes of € 128,695 in financial year 2025.

What is the revenue of Pianite?

As a small company, Pianite is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 278,698.

Pianite (Private Limited) - Overijse - BE0841106103

Dossier Pianite, printed on 15 November 2026 from databakkes.be/en/0841106103/pianite. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Pianite from Overijse, company number BE0841106103, closed financial year 2025 with a result of € 128,695 after tax. For that financial year Pianite recorded a gross margin of € 278,698 and equity of € 549,366. Compared with financial year 2024, the result moved from € 139,261 to € 128,695. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 6, 2026.

What it is worth Healthy

€ 549,366

▼ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 128,695

▼ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 147,483

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 575,883 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 48,830

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go

€ 71,948

▼ 24% vs 2024

€ 23,488 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 10,929

▲ 73% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 26,594

▼ 24% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 228,908 Gross margin 2022: € 228,908 First fiscal year in the series	€ 257,933 Gross margin 2023: € 257,933 ▲ 13% vs 2022 (€ 228,908) Favourable step	€ 289,061 Gross margin 2024: € 289,061 ▲ 12% vs 2023 (€ 257,933) Favourable step	€ 278,698 Gross margin 2025: € 278,698 ▼ 4% vs 2024 (€ 289,061) Unfavourable step	▼ 4%
Profit after taxes	€ 92,056 Profit after taxes 2022: € 92,056 First fiscal year in the series	€ 110,613 Profit after taxes 2023: € 110,613 ▲ 20% vs 2022 (€ 92,056) Favourable step	€ 139,261 Profit after taxes 2024: € 139,261 ▲ 26% vs 2023 (€ 110,613) Favourable step	€ 128,695 Profit after taxes 2025: € 128,695 ▼ 8% vs 2024 (€ 139,261) Unfavourable step	▼ 8%
Equity	€ 898,346 Equity 2022: € 898,346 First fiscal year in the series	€ 958,126 Equity 2023: € 958,126 ▲ 7% vs 2022 (€ 898,346) Favourable step	€ 996,553 Equity 2024: € 996,553 ▲ 4% vs 2023 (€ 958,126) Favourable step	€ 549,366 Equity 2025: € 549,366 ▼ 45% vs 2024 (€ 996,553) Unfavourable step	▼ 45%
Total debts	€ 128,543 Total debts 2022: € 128,543 First fiscal year in the series	€ 169,414 Total debts 2023: € 169,414 ▲ 32% vs 2022 (€ 128,543) Unfavourable step	€ 242,719 Total debts 2024: € 242,719 ▲ 43% vs 2023 (€ 169,414) Unfavourable step	€ 690,870 Total debts 2025: € 690,870 ▲ 185% vs 2024 (€ 242,719) Unfavourable step	▲ 185%
Cash	€ 71,831 Cash 2022: € 71,831 First fiscal year in the series	€ 150,025 Cash 2023: € 150,025 ▲ 109% vs 2022 (€ 71,831) Favourable step	€ 178,304 Cash 2024: € 178,304 ▲ 19% vs 2023 (€ 150,025) Favourable step	€ 147,483 Cash 2025: € 147,483 ▼ 17% vs 2024 (€ 178,304) Unfavourable step	▼ 17%
Land & buildings	€ 206,402 Land & buildings 2022: € 206,402 First fiscal year in the series	€ 194,017 Land & buildings 2023: € 194,017 ▼ 6% vs 2022 (€ 206,402) Unchanged	€ 181,632 Land & buildings 2024: € 181,632 ▼ 6% vs 2023 (€ 194,017) Unchanged	€ 169,248 Land & buildings 2025: € 169,248 ▼ 7% vs 2024 (€ 181,632) Unchanged	▼ 7%
Retained profit	€ 885,946 Retained profit 2022: € 885,946 First fiscal year in the series	€ 945,726 Retained profit 2023: € 945,726 ▲ 7% vs 2022 (€ 885,946) Favourable step	€ 984,153 Retained profit 2024: € 984,153 ▲ 4% vs 2023 (€ 945,726) Favourable step	€ 536,966 Retained profit 2025: € 536,966 ▼ 45% vs 2024 (€ 984,153) Unfavourable step	▼ 45%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 50,833 Dividend 2023: € 50,833 ▲ € 50,033 vs 2022 (€ 800) Unchanged	€ 100,833 Dividend 2024: € 100,833 ▲ 98% vs 2023 (€ 50,833) Unchanged	€ 575,883 Dividend 2025: € 575,883 ▲ € 475,050 vs 2024 (€ 100,833) Unchanged	▲ € 475,050
Bank debt	€ 84,355 Bank debt 2022: € 84,355 First fiscal year in the series	€ 71,281 Bank debt 2023: € 71,281 ▼ 15% vs 2022 (€ 84,355) Favourable step	€ 94,928 Bank debt 2024: € 94,928 ▲ 33% vs 2023 (€ 71,281) Unfavourable step	€ 71,948 Bank debt 2025: € 71,948 ▼ 24% vs 2024 (€ 94,928) Favourable step	▼ 24%
Balance sheet total	€ 1,026,888 Balance sheet total 2022: € 1,026,888 First fiscal year in the series	€ 1,127,540 Balance sheet total 2023: € 1,127,540 ▲ 10% vs 2022 (€ 1,026,888) Unchanged	€ 1,239,272 Balance sheet total 2024: € 1,239,272 ▲ 10% vs 2023 (€ 1,127,540) Unchanged	€ 1,240,236 Balance sheet total 2025: € 1,240,236 Unchanged (€ 1,239,272) Unchanged

By gross margin, Pianite ranks 7th of 32 companies with main activity “Activiteiten van medisch specialisten” in Overijse that publish figures (fiscal year 2025).

Key figures of Pianite, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Pianite the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Pianite?

What happened at Pianite in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 6, 2026 New annual accounts for financial year 2025: profit of € 128,695 (▼ 8% vs 2024). filed late Source: NBB ↗
Nov 29, 2011 Incorporation, published in the Gazette. Source: Staatsblad ↗
Nov 14, 2011 New establishment in Leuven. KBO
2011 Tom Van Severen became a director. NBB

In short

From € 92,056 profit in 2022 to € 128,695 profit in 2025.

Paid € 194,985 in corporate taxes since 2022.

Best year ever: 2024, with € 139,261 profit.

Paid out € 728,349 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Tom Van Severen

Pianite

Behind Pianite is Tom Van Severen.

Directors

According to the 2025 annual accounts

Tom Van Severen

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Jean Tombeurstraat 19 box a

3090 Overijse

2.303.540.063

Naamsestraat 105

3000 Leuven

Active since 14 November 2011

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Traversalgo

€ 247,825 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Overijse

Same main activity (Activiteiten van medisch specialisten), 34 active companies in Overijse, largest first.

Beclinic

€ 1.9 million gross margin · 2025

DR. TESSA DE WANDELER RADIOLOGIE

€ 507,953 gross margin · 2025

BF Resp Oncology

€ 422,084 gross margin · 2025

GRANDJEAN FREDERIC DOCTEUR

€ 384,143 gross margin · 2025

MAPIALEJ

€ 334,553 gross margin · 2025

Dr. Reynaert MDL

€ 293,636 gross margin · 2025

All companies with this activity → Largest companies in Overijse →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

29 November 2011 Source: Deed ↗

VAN SEVEREN Tom Ivonne Antoon(oprichter) 100%

Details

Company number: 0841.106.103
VAT number: BE 0841.106.103
Registered office: Jean Tombeurstraat 19 bus a, 3090 Overijse
Names & denominations: Pianite
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 November 2011
Peppol: Active · Active since 3 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗